York, United Kingdom
York, United Kingdom

Time filter

Source Type

SAN ANTONIO, Texas--(BUSINESS WIRE)--Tissue Regenix Wound Care, Inc., today announced the company has been awarded a group purchasing contract with Premier Inc., a leading healthcare improvement company, for Breakthrough Technology: Bone Tissue Synthetic Implantable Products. The agreement provides Premier members with access to DermaPure® human dermal allograft featuring dCELL® technology for the treatment of complex, acute and chronic wounds. Antony Odell, CEO, Tissue Regenix Group plc commented: “Approval by Premier marks a significant step for DermaPure®. This confirms the unique characteristics of our patented dCELL® technology, the powerful clinical evidence we have collected and the remarkable outcomes it achieves in real world clinical situations.” Tissue Regenix is a leading medical devices company in the field of regenerative medicine. The company's patented decellularisation ('dCELL®') technology removes DNA and other cellular material from animal and human tissue leaving an acellular tissue scaffold which is not rejected by the patient's body which can then be used to repair diseased or worn out body parts. The potential applications of this process are diverse and address many critical clinical needs such as vascular disease, heart valve replacement and knee repair. Tissue Regenix was formed in 2006 when it was spun-out from the University of Leeds. The company commercialises academic research conducted by our partners around the World. In November 2012 Tissue Regenix Group plc set up a subsidiary company in the United States - 'Tissue Regenix Wound Care Inc.', as part of its commercialisation strategy for its dCELL® technology platform. Premier Inc. (NASDAQ: PINC) is a leading healthcare improvement company, uniting an alliance of approximately 3,600 U.S. hospitals and 120,000 other providers. With integrated data and analytics, collaboratives, supply chain solutions, and advisory and other services, Premier enables better care and outcomes at a lower cost. Premier, a Malcolm Baldrige National Quality Award recipient, plays a critical role in the rapidly evolving healthcare industry, collaborating with members to co-develop long-term innovations that reinvent and improve the way care is delivered to patients nationwide. Headquartered in Charlotte, N.C., Premier is passionate about transforming American healthcare. Please visit Premier’s news and investor sites on www.premierinc.com; as well as Twitter, Facebook, LinkedIn, YouTube, Instagram, Foursquare and Premier’s blog for more information about the company.


News Article | May 15, 2017
Site: globenewswire.com

Dublin, May 15, 2017 (GLOBE NEWSWIRE) -- Research and Markets has announced the addition of the "Soft Tissue Repair Global Market - Forecast To 2023" report to their offering. The soft tissue repair global market is expected to grow at high single digit CAGR to reach $21,319.7 million by 2023. Factors driving the soft tissue repair market include, increase in aging population, increase in medical procedures and sports injuries along with technology advancements and growing investment potential in emerging markets are contributing to the growth of soft tissue repair global market. Lack of awareness, limited reimbursements and high cost of procedures are hampering the market growth. Advancement of technology with its wide application areas shows that soft tissue repair market has vast opportunities in the coming years. Soft tissue repair global market is classified based on products, surgeries, applications, and geography. The products segment is divided into four segments i.e., meshes/tissue patches, fixation devices, cardiac repair devices and others. Where, the meshes/tissue patches are further classified into synthetic meshes (absorbable meshes and non-absorbable meshes) and biological meshes (allografts tissue patches and Xenograft). The fixation devices market included products such as suture anchors, interference screws and others. The cardiac repair devices market included products such as heart valves (mechanical heart valve, biologic heart valve) and others. While, the others market includes products such as cornea, otologic grafts, cardiac grafts and tendons and ligament grafts. Soft tissue repair market based on surgery is classified into open surgery and minimally invasive surgery (laparoscopy, arthroscopy, catheter based surgery and robotic surgery). Based on application, the soft tissue repair products are segmented into hernia repair, dental reconstruction, vaginal sling procedure, skin repair, breast reconstruction, orthopedic (dural repair and sports medicine), cardiac repair (transcatheter aortic valve replacement, mechanical heart valve replacement, biological heart valve replacement, annuloplasty ring, MitraClip, occluders, stent grafts and cardiac tissue patches). Based on geography soft tissue repair global market is classified as North America, Europe, Asia Pacific and Rest of the world. North America accounts for the highest market share followed by Europe. The steep rise in aging population, increase in medical procedures and sports injuries along with technology advancements and growing investment potential in emerging markets are driving factors of soft tissue repair products market. However, Asian countries especially China and India are the fastest growing regions with its growing demand for soft tissue repair products. Major players in soft tissue repair market include: Edwards Lifesciences (U.S.), Medtronic PLC (Ireland), Abbott Laboratories (U.S.), Arthrex Inc (U.S.), Johnson & Johnson (U.S.), C.R. Bard Inc, (U.S.), Allergan (Lifecell) (U.S.), Smith & Nephew (U.K.), Integra Lifesciences (U.S.), Livanova (U.K.), Zimmer Biomet (U.S.), Organogenesis (U.S.), etc. Key Topics Covered: 1 Executive Summary 2 Introduction 3 Market Analysis 3.1 Introduction 3.2 Market Segmentation 3.3 Factors Influencing Market 3.3.1 Drivers and Opportunities 3.3.1.1 Increased Incidents of Soft Tissue Injuries 3.3.1.2 Rise in Ageing Population 3.3.1.3 Technological Advancements 3.3.1.4 Increase in Investments and Growth in Emerging Markets 3.3.2 Restrains and Threats 3.3.2.1 Lack of Awareness 3.3.2.2 Limited Reimbursement 3.3.2.3 High Cost of Products 3.3.2.4 Strict Regulations 3.4 Regulatory Affairs 3.5 Reimbursement Scenario 3.6 Patent Analysis 3.7 Technology Advancements 3.7.1 Implant Design 3.7.2 Biomaterial Advancements 3.8 Funding Scenario 3.9 Soft Tissue Repair Products - Deals 3.10 Upcoming Technology and Product Launch 3.11 Clinical Trials 3.12 Porter's Five Force Analysis 3.13 Supply Chain Analysis 3.14 Market Share Analysis 4 Soft Tissue Repair Global Market, by Products 4.1 Introduction 4.2 Mesh/Tissue Patches 4.3 Fixation Devices 4.4 Cardiac Repair Devices 4.5 Others 5 Soft Tissue Repair Global Market, by Surgery 5.1 Introduction 5.2 Open Surgery 5.3 Minimally Invasive Surgery 5.3.1 Laparoscopic Surgery 5.3.2 Arthroscopic Surgery 5.3.3 Catheter-Based Surgery 5.3.4 Robotic Surgery 6 Soft Tissue Repair Global Market, by Application 6.1 Introduction 6.2 Hernia Repair 6.3 Dental Reconstruction 6.4 Vaginal Slings 6.5 Skin Repair 6.6 Breast Reconstruction 6.7 Orthopedic 6.8 Cardiac Repair 6.9 Other Soft Tissue Repairs 7 Soft Tissue Repair Market, by Region 8 Competitive Landscape 8.1 Introduction 8.2 Approvals 8.3 Acquisitions & Mergers 8.4 New Product Launches 8.5 Agreements 8.6 Other Strategies 9 Major Companies Companies Mentioned - A.M.I. GmbH - Abbott Laboratories - Abiss - Admedus - Advanced Medical Solutions Group Plc - Allergan Plc - Alliqua Biomedical, Inc - Allosource - Altimed JSC - Angiologica BM SRL - Aroa Biosurgery Ltd. - Arthrex Inc - Aspide Medical S.A.S - Atrium Medical Corporation (Maquet Getinge Group) - Axogen, Inc - Axolotl Biologix - B.Braun - Baxter International Inc. (Synovis Surgical) - Bentley Healthcare Private Limited - Betatech Medical - Biocer Entwicklungs-GmbH - Biocomposites Ltd. - Biohorizons - Biomtlante - Boston Scientific - Botiss Biomaterials GmbH - Braile Bio Medica - C.R.Bard Inc. - Caldera Medical Inc. - Changzhou Dahua Corp., Ltd - China Regenerative Medicine International Limited - CL Medical - Colibri Heart Valve Llc - Collagen Matrix, Inc. - Collplant Holdings Ltd - Coloplast - Colorado Therapeutics Llc - Conmed - Cook Medical, Inc. - Corin Group Plc - Cousin Biotech - Cryolife, Inc - CTI Group (Vitrex Medical A/S) - Dieter Marquardt Medizintechnik GmbH - Dipromed S.R.L - Dolphin Sutures (Futura Surgicare Pvt Ltd) - DSM Biomedical B.V. - Edwards Lifesciences - Endologix, Inc. - Fine Surgicals - Geistlich Pharma AG - Grena Ltd - Grikin Advanced Materials - Groupe Lepine - Guanhao Biotech - Harbor Medtech - Helioscopie - Hernia Mesh S.R.L - In2Bones SAS - Incisive Surgical, Inc - Inion OY - Insightra Medical Inc - Integra Lifesciences - Intercus GmbH - Jellagen Pty Ltd - Jenavalve Technology - Johnson & Johnson - Jotec GmbH - Katena Products, Inc. - Kator - Kerecis - Klas Medical - Kollsut USA, Llc - Labcor Laboratórios Ltda. - Lattice Biologics Ltd. - Le Maitre Vascular, Inc. - Lepu Medical - Lifebond Ltd. - Lifenet Healthcare Inc - Lifetech Scientific Corporation - Livanova Plc - Lotus Surgical Pvt Ltd - Medprin Biotech GmbH - Medshape, Inc. - Medtentia International Ltd OY - Medtronic, Inc - Micro Interventional Devices - Mimedx - Miromatrix Medical - Nano Endoluminal S.A. - Nicast, Ltd - Noraker - Novus Scientific - Nurami Medical - Occlutech International AB - Organogenesis, Inc. - Orthocell Ltd. - Orthod Group Ltd - Ortosintese Indústria E Comércio - Parametrics Medical - PFM Medical AG - Pontis Orthopaedics, Llc - Proxy Biomedical Ltd. - Purple Surgical - RTI Surgical, Inc. - S & G Biotech, Inc. - Skye Orthobiologics, Llc - Smith & Nephew Plc - Sofregen Medical Inc. - Strait Access Technologies Pty Ltd - Stryker Corporation - Synthasome - Teknimed S.A.S. - Tela Bio, Inc. - THT Bioscience Group (Swing Technologies) - Tissue Regenix Group - Tissuegraft SRL - Transeasy Medical Tech.Co.Ltd - Unisur Life Care Pvt Ltd - Valcare Medical Ltd. - Vitathreads, Llc - Vitrex Medical A/S - W. L. Gore & Associates, Inc - Wright Medical Group N.V - Zimmer Biomet Inc. For more information about this report visit http://www.researchandmarkets.com/research/txq29g/soft_tissue About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.


News Article | May 15, 2017
Site: globenewswire.com

Dublin, May 15, 2017 (GLOBE NEWSWIRE) -- Research and Markets has announced the addition of the "Soft Tissue Repair Global Market - Forecast To 2023" report to their offering. The soft tissue repair global market is expected to grow at high single digit CAGR to reach $21,319.7 million by 2023. Factors driving the soft tissue repair market include, increase in aging population, increase in medical procedures and sports injuries along with technology advancements and growing investment potential in emerging markets are contributing to the growth of soft tissue repair global market. Lack of awareness, limited reimbursements and high cost of procedures are hampering the market growth. Advancement of technology with its wide application areas shows that soft tissue repair market has vast opportunities in the coming years. Soft tissue repair global market is classified based on products, surgeries, applications, and geography. The products segment is divided into four segments i.e., meshes/tissue patches, fixation devices, cardiac repair devices and others. Where, the meshes/tissue patches are further classified into synthetic meshes (absorbable meshes and non-absorbable meshes) and biological meshes (allografts tissue patches and Xenograft). The fixation devices market included products such as suture anchors, interference screws and others. The cardiac repair devices market included products such as heart valves (mechanical heart valve, biologic heart valve) and others. While, the others market includes products such as cornea, otologic grafts, cardiac grafts and tendons and ligament grafts. Soft tissue repair market based on surgery is classified into open surgery and minimally invasive surgery (laparoscopy, arthroscopy, catheter based surgery and robotic surgery). Based on application, the soft tissue repair products are segmented into hernia repair, dental reconstruction, vaginal sling procedure, skin repair, breast reconstruction, orthopedic (dural repair and sports medicine), cardiac repair (transcatheter aortic valve replacement, mechanical heart valve replacement, biological heart valve replacement, annuloplasty ring, MitraClip, occluders, stent grafts and cardiac tissue patches). Based on geography soft tissue repair global market is classified as North America, Europe, Asia Pacific and Rest of the world. North America accounts for the highest market share followed by Europe. The steep rise in aging population, increase in medical procedures and sports injuries along with technology advancements and growing investment potential in emerging markets are driving factors of soft tissue repair products market. However, Asian countries especially China and India are the fastest growing regions with its growing demand for soft tissue repair products. Major players in soft tissue repair market include: Edwards Lifesciences (U.S.), Medtronic PLC (Ireland), Abbott Laboratories (U.S.), Arthrex Inc (U.S.), Johnson & Johnson (U.S.), C.R. Bard Inc, (U.S.), Allergan (Lifecell) (U.S.), Smith & Nephew (U.K.), Integra Lifesciences (U.S.), Livanova (U.K.), Zimmer Biomet (U.S.), Organogenesis (U.S.), etc. Key Topics Covered: 1 Executive Summary 2 Introduction 3 Market Analysis 3.1 Introduction 3.2 Market Segmentation 3.3 Factors Influencing Market 3.3.1 Drivers and Opportunities 3.3.1.1 Increased Incidents of Soft Tissue Injuries 3.3.1.2 Rise in Ageing Population 3.3.1.3 Technological Advancements 3.3.1.4 Increase in Investments and Growth in Emerging Markets 3.3.2 Restrains and Threats 3.3.2.1 Lack of Awareness 3.3.2.2 Limited Reimbursement 3.3.2.3 High Cost of Products 3.3.2.4 Strict Regulations 3.4 Regulatory Affairs 3.5 Reimbursement Scenario 3.6 Patent Analysis 3.7 Technology Advancements 3.7.1 Implant Design 3.7.2 Biomaterial Advancements 3.8 Funding Scenario 3.9 Soft Tissue Repair Products - Deals 3.10 Upcoming Technology and Product Launch 3.11 Clinical Trials 3.12 Porter's Five Force Analysis 3.13 Supply Chain Analysis 3.14 Market Share Analysis 4 Soft Tissue Repair Global Market, by Products 4.1 Introduction 4.2 Mesh/Tissue Patches 4.3 Fixation Devices 4.4 Cardiac Repair Devices 4.5 Others 5 Soft Tissue Repair Global Market, by Surgery 5.1 Introduction 5.2 Open Surgery 5.3 Minimally Invasive Surgery 5.3.1 Laparoscopic Surgery 5.3.2 Arthroscopic Surgery 5.3.3 Catheter-Based Surgery 5.3.4 Robotic Surgery 6 Soft Tissue Repair Global Market, by Application 6.1 Introduction 6.2 Hernia Repair 6.3 Dental Reconstruction 6.4 Vaginal Slings 6.5 Skin Repair 6.6 Breast Reconstruction 6.7 Orthopedic 6.8 Cardiac Repair 6.9 Other Soft Tissue Repairs 7 Soft Tissue Repair Market, by Region 8 Competitive Landscape 8.1 Introduction 8.2 Approvals 8.3 Acquisitions & Mergers 8.4 New Product Launches 8.5 Agreements 8.6 Other Strategies 9 Major Companies Companies Mentioned - A.M.I. GmbH - Abbott Laboratories - Abiss - Admedus - Advanced Medical Solutions Group Plc - Allergan Plc - Alliqua Biomedical, Inc - Allosource - Altimed JSC - Angiologica BM SRL - Aroa Biosurgery Ltd. - Arthrex Inc - Aspide Medical S.A.S - Atrium Medical Corporation (Maquet Getinge Group) - Axogen, Inc - Axolotl Biologix - B.Braun - Baxter International Inc. (Synovis Surgical) - Bentley Healthcare Private Limited - Betatech Medical - Biocer Entwicklungs-GmbH - Biocomposites Ltd. - Biohorizons - Biomtlante - Boston Scientific - Botiss Biomaterials GmbH - Braile Bio Medica - C.R.Bard Inc. - Caldera Medical Inc. - Changzhou Dahua Corp., Ltd - China Regenerative Medicine International Limited - CL Medical - Colibri Heart Valve Llc - Collagen Matrix, Inc. - Collplant Holdings Ltd - Coloplast - Colorado Therapeutics Llc - Conmed - Cook Medical, Inc. - Corin Group Plc - Cousin Biotech - Cryolife, Inc - CTI Group (Vitrex Medical A/S) - Dieter Marquardt Medizintechnik GmbH - Dipromed S.R.L - Dolphin Sutures (Futura Surgicare Pvt Ltd) - DSM Biomedical B.V. - Edwards Lifesciences - Endologix, Inc. - Fine Surgicals - Geistlich Pharma AG - Grena Ltd - Grikin Advanced Materials - Groupe Lepine - Guanhao Biotech - Harbor Medtech - Helioscopie - Hernia Mesh S.R.L - In2Bones SAS - Incisive Surgical, Inc - Inion OY - Insightra Medical Inc - Integra Lifesciences - Intercus GmbH - Jellagen Pty Ltd - Jenavalve Technology - Johnson & Johnson - Jotec GmbH - Katena Products, Inc. - Kator - Kerecis - Klas Medical - Kollsut USA, Llc - Labcor Laboratórios Ltda. - Lattice Biologics Ltd. - Le Maitre Vascular, Inc. - Lepu Medical - Lifebond Ltd. - Lifenet Healthcare Inc - Lifetech Scientific Corporation - Livanova Plc - Lotus Surgical Pvt Ltd - Medprin Biotech GmbH - Medshape, Inc. - Medtentia International Ltd OY - Medtronic, Inc - Micro Interventional Devices - Mimedx - Miromatrix Medical - Nano Endoluminal S.A. - Nicast, Ltd - Noraker - Novus Scientific - Nurami Medical - Occlutech International AB - Organogenesis, Inc. - Orthocell Ltd. - Orthod Group Ltd - Ortosintese Indústria E Comércio - Parametrics Medical - PFM Medical AG - Pontis Orthopaedics, Llc - Proxy Biomedical Ltd. - Purple Surgical - RTI Surgical, Inc. - S & G Biotech, Inc. - Skye Orthobiologics, Llc - Smith & Nephew Plc - Sofregen Medical Inc. - Strait Access Technologies Pty Ltd - Stryker Corporation - Synthasome - Teknimed S.A.S. - Tela Bio, Inc. - THT Bioscience Group (Swing Technologies) - Tissue Regenix Group - Tissuegraft SRL - Transeasy Medical Tech.Co.Ltd - Unisur Life Care Pvt Ltd - Valcare Medical Ltd. - Vitathreads, Llc - Vitrex Medical A/S - W. L. Gore & Associates, Inc - Wright Medical Group N.V - Zimmer Biomet Inc. For more information about this report visit http://www.researchandmarkets.com/research/txq29g/soft_tissue About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Loading Tissue Regenix collaborators
Loading Tissue Regenix collaborators